Skip main navigation

£199.99 £139.99 for one year of Unlimited learning. Offer ends on 28 February 2023 at 23:59 (UTC). T&Cs apply

Find out more

The changing landscape of genomic technologies

In this video, we will give an overview of the changing landscape of genomic technologies over the last 60 years.
In the last 60 years, our ability to study the human genome has changed immeasurably. Before 1956, we did not even the exact number of chromosomes present within human cells. Our ability to look at chromosomes down a microscope in the form of a karyotype dates back to this time and was the main diagnostic technique used in cytogenetics until the 21st century. It was not until the 1970s that a scalable, economical method for reading the sequence of DNA was introduced. Using this technology in combination with the new method to amplify sections of DNA, known as PCR, allowed scientists to map the first human disease gene in the early 1980s, the cause of a devastating neurological condition called Huntington’s Disease.
The increased knowledge of the sequence of the human genome allowed researchers to develop fluorescent probes which would stick to specific places on human chromosomes. This enabled cytogeneticists to apply the probes to chromosomes and cells from patients, to see if those specific regions of the genome were present, absent, or duplicated– a technique known as Fluorescent In Situ Hybridisation, or FISH. Meanwhile, academics across the world were in a huge race with a private company to be the first to sequence the human genome, trying to keep the genetic sequence free to use for all humanity. This fierce battle was won just in time by the public sector and ensured that all researchers had free access to the human genome for health care purposes.
The published reference sequence of the human genome meant that probes could be developed across the entire set of 23 chromosomes and allowed scientists to develop a technique called Array CGH, allowing cytogeneticists to interrogate gains and losses of any parts of the genome. We will discuss this technique and the impact it has had on clinical practice in the next few steps. Finally, the drive to sequence the first human genome had pushed scientists into developing ever faster and economical methods of DNA sequencing, resulting in the development of what became known as Next-Generation Sequencing, or NGS technologies.
Since the publication of the first genome sequenced using NGS from James Watson, one half of the duo who cracked the structure of DNA back in 1952, the cost and length of time taken to sequence the human genome has fallen exponentially. The number of disease genes identified now stands at over 4,000, with new genes being reported in the medical literature every month. This evolution in genomic technologies over just over half a century is about to transform the practice of health care.

This video looks at how various technologies have impacted on medicine over the last 60 years.

Talking point

During the video, we learnt that, in 1998, a private company run by Craig Venter, initially called the Institute of Genomic Research and later renamed Celera Genomics, announced that they were working to sequence the human genome.

Celera Genomics planned only to make the information from their sequencing available to paying customers with a plan to patent 6000 genes. Celera was in direct competition with the Human Genome Project, an international consortium working to make genomic data freely available online.

As it turned out, both Celera and the Human Genome Project published their draft human genome sequences in 2000.

  • Let us know what you think about the race to the human genome. Can you imagine a world where the human genome sequence is privately owned? How would this have shaped medicine today?
  • Some people suggest that the competition was a good thing – accelerating discovery. What do you think?

Do you want to know more?

If you’re interested to read more about the race to decipher the human genome, check out this story on the YourGenome website.

This article is from the free online

The Genomics Era: the Future of Genetics in Medicine

Created by
FutureLearn - Learning For Life

Our purpose is to transform access to education.

We offer a diverse selection of courses from leading universities and cultural institutions from around the world. These are delivered one step at a time, and are accessible on mobile, tablet and desktop, so you can fit learning around your life.

We believe learning should be an enjoyable, social experience, so our courses offer the opportunity to discuss what you’re learning with others as you go, helping you make fresh discoveries and form new ideas.
You can unlock new opportunities with unlimited access to hundreds of online short courses for a year by subscribing to our Unlimited package. Build your knowledge with top universities and organisations.

Learn more about how FutureLearn is transforming access to education